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Abstract
Branched-chain amino acid (BCAA; valine, leucine, and isoleucine) supplementation is often 
beneficial to energy expenditure; however, paradoxically increased circulating BCAA levels are 
linked to obesity and diabetes. The mechanisms of the paradox remain elusive. Here we report 
that, upon cold exposure, brown adipose tissue (BAT) actively utilizes BCAA in the mitochondria 
for thermogenesis and promotes systemic BCAA clearance in mice and humans. In turn, a BAT-
specific defect in BCAA catabolism attenuates systemic BCAA clearance, BAT fuel oxidation, 
and thermogenesis, leading to diet-induced obesity and glucose intolerance. Mechanistically, 
active BCAA catabolism in BAT is mediated by SLC25A44, a previously uncharacterized 
mitochondrial transporter for BCAA. The present study suggests that BAT serves as a significant 
metabolic-filter that controls BCAA clearance via SLC25A44, thereby contributing to the 
improvement of metabolic health.
Keywords
Brown adipose tissue; Thermogenesis; Branched-chain amino acids; mitochondrial transporter; 
SLC25A44
Besides its well-known function as a thermogenic organ, studies by positron emission 
tomography-computed tomography (PET/CT) with 18F-fluorodeoxyglucose (18FDG) and 
fatty acid tracers demonstrate that BAT serves as a metabolic-sink for glucose and fatty 
acids1–3. Such a function is tightly coupled with its ability to improve metabolic health: cold 
acclimation stimulates uptake of glucose but also triglyceride-rich lipoproteins and fatty 
acids in BAT, thereby contributing to an improvement in systemic lipid metabolism4,5. It 
remains unknown, however, whether BAT contributes to the clearance of any other 
metabolites, and how such processes are regulated. Accordingly, we performed an unbiased 
metabolite analysis on the sera from healthy human subjects (male, age 23.4 ± 0.6 years old, 
n =33) with high BAT activity (SUV > 4.03, n = 17) and low BAT activity (SUV ≦ 4.03, n = 
16) at 27°C (thermoneutral, TN) and following cold exposure (19°C) for 2 hours 
(Supplementary Table1). Subjects with SUV > 4.03 were considered as the high BAT group, 
based on the median of the subjects in the study (Fig.1a). The rationale of 19°C as a cold 
stimulus was based on the result that BAT thermogenesis is stimulated at 19°C in adults 
without triggering skeletal muscle shivering (Extended Data Fig.1a). Cold exposure 
stimulated lipolysis in adipose tissue, leading to a significant increase in circulating non-
esterified fatty acids (NEFA) levels in both groups, whereas cold exposure did not change 
blood glucose levels (Extended Data Fig.1b,c).
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Cold-activated BAT promotes systemic BCAA clearance
Unexpectedly, we found that serum concentration of valine (Val) was significantly reduced, 
preferentially in high BAT subjects following cold exposure, whereas no statistical change 
was seen in low BAT subjects (Fig.1b). The cold-induced reduction in serum Val levels 
showed a significant inverse correlation with BAT activity (SUV) by 18F-FDG-PET imaging 
(Fig.1c). Similarly, cold-induced changes in leucine (Leu) and total BCAA levels were 
inversely correlated with SUV, whereas no amino acids except Val and Leu showed a 
significant correlation (Fig.1d, Extended Data Fig.1d, Supplementary Table2). While 
skeletal muscle is a major organ that utilizes BCAA, muscle mass showed no correlation 
with cold-induced changes in BCAA levels (Extended Data Fig.1e). Consistent with the 
human study, plasma metabolomics in obese mice found that cold exposure significantly 
reduced plasma Val, Leu, and Ile levels (Fig.1e, Extended Data Fig.1f).
These observations caught our attention because epidemiological studies demonstrate that 
increased circulating BCAA levels are strongly associated with obesity, insulin resistance, 
and type 2 diabetes in humans and rodents6–8, despite the fact that BCAA supplementation 
in healthy subjects is often associated with beneficial effects on muscle growth and energy 
expenditure9. Adipose tissue appears to contribute to the regulation of circulating BCAA 
levels as previous studies show that expression or activity of mitochondrial BCAA enzymes 
in the white adipose tissue (WAT), such as the branched-chain α-keto acid dehydrogenase 
(BCKDH) complex, are reduced under obese and diabetic states10–13, and that 
transplantation of WAT from wild-type mice into branched chain aminotransferase (BCAT2) 
deficient mice reduces circulating BCAA levels13. The extent to which cold acclimation 
controls systemic BCAA homeostasis via BAT remains unknown.
Thus, we next employed a PET/CT scan with 18F-fluciclovine, a Leu analog tracer, to 
visualize Leu uptake in BAT. Following cold acclimation, 18F-fluciclovine-PET/CT detected 
a robust increase in 18F-fluciclovine uptake in the BAT and a modest increase in the inguinal 
WAT of mice (Fig.1f,g). While the basal SUV in the liver and heart was higher than BAT, no 
significant change was seen in these organs following cold exposure (Extended Data Fig.2a). 
Upon cold exposure, we found along with a recent study14 that BAT displayed the highest 
Val oxidation relative to other metabolic organs, including inguinal WAT, epididymal WAT, 
and gastrocnemius muscle of mice (Extended Data Fig.2b,c). Furthermore, Val oxidation in 
differentiated human brown adipocytes was significantly higher than white adipocytes and 
further enhanced by norepinephrine (NE) (Extended Data Fig.2d). Of note, transcriptomics 
and proteomics data in mice and humans15–17 showed that over 60 % of the BCAA catabolic 
enzymes, including the rate-limiting enzymes BCAT2, were highly enriched in brown 
adipocytes relative to white adipocytes (Extended Data Fig.2e,f). Our previous analysis5 also 
found that the BCAA catabolic pathway was highly induced by cold exposure selectively in 
the supraclavicular BAT but not in the abdominal WAT (Extended Data Fig.2g). It is worth 
noting that BCAAs are oxidized within the mitochondria of BAT because brown fat 
predominantly expresses the mitochondria-localized form BCAT2, but not the cytosolic 
isoform (BCAT1) (Extended Data Fig.2h,i). Despite this knowledge, the mitochondrial 
transporter for BCAAs is unidentified, and as such, it remains unknown how BCAAs are 
utilized in brown adipocytes.
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To determine if BAT contributes to systemic BCAA clearance, we generated a BAT-ablation 
mouse model in which Peroxisome proliferator-activated receptor-γ (PPARγ) was deleted 
in uncoupling protein1 (UCP1)-expressing thermogenic adipocytes (PpargUcp1 KO, Ucp1-
Cre;Ppargflox/flox). In contrast to littermate controls (Ppargflox/flox), the presumptive BAT in 
PpargUcp1 KO mice was primarily composed of unilocular adipocytes and fibrotic tissues 
(Fig.1h). Following cold exposure, plasma BCAA concentration in control mice was 
significantly reduced, whereas such a decrease was not seen PpargUcp1 KO mice (Fig.1i).
A BAT-specific defect in BCAA catabolism impairs energy metabolism
To examine the extent to which BCAA catabolism in BAT controls energy homeostasis, we 
next generated a mouse model in which BCAA oxidation is impaired specifically in the BAT 
(BckdhaUCP1 KO mice, Ucp1-Cre;Bckdhaflox/flox) (Fig.2a, Extended Data Fig.3a–c). While 
no difference was seen in the BAT mass and thermogenic gene expression between the 
genotypes on a regular diet (Extended Data Fig.3d,e), the core-body temperature of 
BckdhaUCP1 KO mice was significantly lower than controls after cold exposure without 
affecting muscle shivering (Fig.2b, Extended Data Fig.3f). Tissue-temperature recording 
also detected impaired thermogenesis in the BAT of BckdhaUCP1 KO mice following NE 
treatment, whereas no change was seen in muscle and liver temperature (Fig.2c, Extended 
Data Fig.3g). Importantly, BckdhaUCP1 KO mice were intolerant to oral BCAA challenge 
relative to control mice (Fig.2d, Extended Data Fig.3h). Similarly, BckdhaUCP1 KO mice 
displayed higher plasma BCAA levels than controls following cold exposure (Extended Data 
Fig.3i). These results indicate that BCAA oxidation is required for BAT thermogenesis and 
systemic BCAA clearance.
To examine how a cold stimulus alters BCAA utilization in brown fat, we next employed 
capillary electrophoresis time-of-flight mass spectrometry (CE-TOFMS) and performed Leu 
stable isotope tracing in differentiated human brown adipocytes. The mole percent 
enrichment (MPE) of TCA cycle intermediates derived from [U-13C6] Leu was quantified 
following NE treatment for one hour (Extended Data Fig.4a, Supplementary Table3). We 
found that acute NE treatment significantly increased MPE of TCA intermediates, including 
succinate (Fig.2e, Extended Data Fig.4b) although the fraction contribution of labeled Leu to 
the TCA cycle was relatively small. This rapid NE-stimulated BCAA oxidation is aligned 
with increased protein expression of many BCAA oxidation enzymes in the BAT 
mitochondria within 8 hours after cold exposure (Extended Data Fig.4c,d), and also the 
report that BCAA is rapidly oxidized in BAT14. Of note, Val supplementation rapidly 
increased oxygen consumption rate (OCR) in human brown adipocytes when stimulated 
with NE (Extended Data Fig.4e). The stimulatory effect requires the generation of a TCA 
cycle intermediate succinate: inhibition of succinyl coenzyme A synthetase (SCS) or 
succinate dehydrogenase (SDH) by vanadate or malonate, respectively, blunted the Val effect 
on OCR (Extended Data Fig.4f,g). We also found that supplementation of Val, Leu, or Ile 
significantly enhanced NE-stimulated thermogenesis in brown adipocytes in a UCP1-
dependent fashion (Extended Data Fig.4h,i). BCAA supplementation or pharmacological 
BCAT2 activation significantly increased brown fat respiration in a BCKDHA-dependent 
manner, while the reduced respiration in Bckdha-deficient cells was not due to a general 
mitochondrial defect because succinate supplementation, but not α-ketoisovalerate (KIV), 
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restored NE-stimulated thermogenesis in Bckdha-deficient brown adipocytes (Extended 
Data Fig.4i,j). Previous studies report that BCAA catabolism fuels de novo lipogenesis by 
generating monomethyl branched-chain fatty acids (mmBCFAs), and mmBCFA synthesis in 
BAT is activated after one-month-cold acclimation18,19. Consistent with the studies, 
proteomics data found that the expression of mmBCFA synthesis enzymes, including 
carnitine acetyltransferase (CrAT), are increased after 3-week-cold acclimation, while many 
BCAA oxidative enzymes in the mitochondria are rapidly induced within 8 hours of cold 
exposure and subsequently down-regulated (Extended Data Fig.4c,d). The data suggest a 
dynamic shift in BCAA utilization during cold accumulation in BAT, i.e., acute cold 
exposure activates BCAA oxidation in the TCA cycle, whereas chronic cold gradually 
promotes mmBCFA synthesis.
Next, we asked the degree to which a BAT-specific defect in BCAA catabolism influences 
whole-body metabolism. On a high-fat diet, BckdhaUCP1 KO mice gained significantly more 
body-weight than littermate controls due to increased adipose tissue and liver mass, but not 
to changes in lean mass or food intake (Fig.2f, Extended Data Fig.5a–c). Consistent with the 
previous studies that BAT thermogenesis controls hepatic triglyceride clearance4,20, the liver 
of BckdhaUCP1 contained significantly higher levels of triglycerides than that of controls 
(Extended Data Fig.5d). Importantly, BckdhaUCP1 KO mice exhibited systemic glucose 
intolerance and insulin resistance relative to controls (Fig.2g,h). Furthermore, glucose 
oxidation in the BAT of BckdhaUCP1 KO was significantly reduced relative to controls (Fig.
2i). Fatty acid oxidation in the BAT of BckdhaUCP1 KO was modestly reduced relative to 
controls (Extended Data Fig.5e). The impaired glucose oxidation in BckdhaUCP1 KO mice 
was associated with reduced pyruvate dehydrogenase (PDH) activity in the BAT and 
inguinal WAT, and also with increased phosphorylation of the E1 subunit of PDH at S300 
and S293 to a lesser degree (Fig.2j, Extended Data Fig.5f–h).
SLC25A44 mediates mitochondrial BCAA transport
Recognizing the role of BCAA catabolism in BAT thermogenesis, we next sought to answer 
the long-standing question: how do cells uptake BCAAs into the mitochondria? As 
described earlier, brown adipocytes in humans and mice predominantly express the 
mitochondria-localized isoform BCAT2, but the mitochondrial BCAA transporter remains 
uncharacterized. Hence, we hypothesized that thermogenic adipocytes would express as-of-
yet unidentified mitochondrial BCAA transporter. In this regard, SLC25A family members 
are promising candidates because many of the mitochondrial amino acid transporters belong 
to this solute carrier transporter family21. Besides SLC25A20 (carnitine/acylcarnitine 
transporter) and SLC25A22 (glutamate transporter), transcriptome analyses identified two 
uncharacterized SLC25A members, SLC25A39 and SLC25A44, that were abundantly 
expressed in mouse and human BAT (Fig.3a, Extended Data Fig.6a). mRNA expression of 
SLC25A44, but not SLC25A39, in the human supraclavicular BAT was significantly 
increased after cold exposure and showed a positive correlation with UCP1 and BCKDHA 
mRNA levels (Fig.3b, Extended Data Fig.6b). SLC25A44 protein was localized to the 
mitochondria and expressed at the highest level in the BAT relative to other metabolic organs 
(Fig. 3c, Extended Data Fig. 6c,d). In addition, SLC25A44 expression was increased during 
brown adipogenesis (Extended Data Fig. 6e–g).
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To determine the function of SLC25A44, we generated Slc25a44 KO brown adipocytes by 
CRISPR-Cas9 (Extended Data Fig.7a). Mitochondrial BCAA uptake assay showed that Val 
and Leu uptake was selectively and significantly reduced in Slc25a44 KO cells, whereas 
Slc25a44 deletion did not affect the mitochondrial uptake of other amino acids (Fig.3d, 
Extended Data Fig.7b,c). Similarly, depletion of Slc25a44 by lentivirus shRNAs abrogated 
mitochondrial Val and Leu uptake, whereas Slc25a39 depletion did not affect Val and Le 
uptake (Extended Data Fig.7d,e). Conversely, ectopic expression of SLC25A44 in a 
neuroblastoma cell line (Neuro2a cells) with undetectable endogenous SLC25A44 
sufficiently and selectively restores mitochondrial Val and Leu uptake (Fig.3e, Extended 
Data Fig.7f).
To characterize SLC25A44 in a cell-free system, we next prepared liposomes that were 
fused with the mitochondrial inner membrane from Slc25a44 KO brown adipocytes or KO 
cells that ectopically expressed Slc25a44 (Extended Data Fig.7g,h). In the liposomes 
preloaded with Leu, we observed a robust and rapid Leu uptake in the mitochondrial-
liposomes from SLC25A44-expressing cells, whereas no detectable Leu uptake was 
measured in the control group (Fig.3f, Extended Data Fig.7i). No difference was found in 
Glu uptake between the two groups (Extended Data Fig.7j). As an alternative cell-free 
system, we reconstituted proteo-liposomes by fusing liposomes with purified SLC25A44 
protein (Extended Data Fig.7k,l). Consistent with the mitochondrial-liposome, we found 
active Leu uptake into the proteo-liposomes with purified SLC25A44 (Extended Data Fig.
7m).
SLC25A44 is required for BCAA catabolism and BAT thermogenesis
To determine the role of SLC25A44 in vivo, we employed a modified CRISPR system, 
catalytically inactive Cas9 protein (dCas9) fused to Krüppel associated box (KRAB) 
domain22. Adeno-associated virus (AAV) expressing a guide RNA (gRNA) targeting 
Slc25a44 or EGFP (control) was injected into the interscapular BAT of dCas9-KRAB mice22 
(Extended Data Fig.8a–c). This system allowed for BAT-selective depletion of SLC25A44 
(Slc25a44BAT KD) (Fig.4a,b, Extended Data Fig.8d,e). We found that brown adipocytes in 
Slc25a44BAT KD mice contained larger lipid droplets than those in control mice (Fig.4c). 
Moreover, NE-induced BAT thermogenesis in Slc25a44BAT KD mice was significantly 
impaired relative to controls without affecting muscle thermogenesis (Fig.4d). Next, we 
generated transgenic mice expressing gRNA targeting Slc25a44, which were subsequently 
crossed with dCas9-KRAB mice to generate SLC25A44 deficient (Slc25a44 KD) mice 
(Extended Data Fig.9a,b). Transcriptional analyses detected no compensatory change in 
other SCL25A members in Slc25a44-KD brown fat (Extended Data Fig.9c,d). Similar to 
Slc25a44BAT KD mice, the BAT of Slc25a44 KD mice contained larger lipid droplets and 
higher levels of triglycerides relative to that of controls, whereas the morphology of WAT, 
liver, and muscle of Slc25a44 KD was normal (Extended Data Fig.9e,f). Although we found 
no difference in the expression of Ucp1 and FA synthesis/oxidation pathway between the 
two groups, the core-body temperature of Slc25a44 KD mice was significantly lower than 
controls following cold exposure without affecting muscle shivering (Fig. 4e, Extended Data 
Fig.9g–i). Tissue temperature recording confirmed that NE-stimulated BAT thermogenesis 
was impaired in Slc25a44 KD mice (Extended Data Fig.9j). Furthermore, Val oxidation in 
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the BAT of Slc25a44 KD mice was lower than controls, indicating that SLC25A44 is the 
primary BCAA transporter in BAT (Fig.4f). Importantly, cold exposure failed to lower 
plasma BCAA concentration in Slc25a44-KD mice (Fig.4g). These results indicate that 
SLC25A44 is required for cold-stimulated BAT thermogenesis and systemic BCAA 
clearance in vivo.
To determine the cell-autonomous function of SLC25A44 in brown adipocytes, we depleted 
Slc25a44 in brown preadipocytes by lentiviral shRNAs targeting SLC25A44 (Extended Data 
Fig.10a,b). We found that SLC25A44 depletion caused a significant reduction in NE-
induced OCR in the presence of Val (Extended Data Fig.10c,d). Of note, depletion of 
SLC25A44 did not causes a general mitochondrial defect because supplementation of KIV 
or succinate, which would bypass mitochondria BCAA transport, restored NE-induced OCR 
in Slc25a44 KO cells (Fig.4h, Extended Data Fig.10e). Additionally, SLC25A44-depleted 
brown adipocytes displayed active mitochondrial respiration (Extended Data Fig.10f,g). 
Conversely, overexpression of Slc25a44 in mouse inguinal WAT-derived adipocytes or 
C2C12 myotubes significantly increased mitochondrial Val uptake and oxidation, and 
cellular respiration (Fig.4i, Extended Data Fig.10h–m).
Discussion
Our study suggests the following model (Fig.4j): besides glucose and fatty acids, cold 
stimuli potently increase mitochondrial BCAA uptake and oxidation in BAT, leading to 
enhanced BCAA clearance in the circulation. This process requires SLC25A44, a previously 
uncharacterized mitochondrial BCAA transporter in brown adipocytes. In turn, defective 
BCAA catabolism in BAT leads to impaired BCAA clearance and thermogenesis, leading to 
the development of diet-induced obesity and glucose intolerance.
This model provides important implications in the regulation of systemic BCAA metabolism 
under an obese or diabetic state in which impaired BAT activity and increased circulating 
BCAA levels are observed in humans and rodents. It has been suggested that the 
accumulation of incompletely oxidized intermediates derived from BCAA oxidation, such as 
3-hydroxyisobutyrate (3-HIB), cause insulin resistance9,23,24. Conversely, lowering 
circulating BCAA levels by inhibiting the kinase BDK or overexpression of the phosphatase 
PPM1K in the liver improves glucose tolerance independently from body weight loss in 
rats25. Furthermore, reduced mitochondrial BCAA oxidation and subsequent accumulation 
of intracellular BCAA concentration leads to constitutive activation of mTOR signaling, 
resulting in persistent IRS-1 phosphorylation by mTORC1 and inhibition of insulin 
signaling6,23,26. The present study suggests a distinct yet non-mutually exclusive mechanism 
in which impaired BAT activity under an obese or diabetic state reduces systemic BCAA 
clearance, while active BAT acts as a significant metabolic-filter for circulating BCAA and 
protects against obesity and insulin resistance. It is conceivable that enhanced mitochondrial 
BCAA catabolism via SLC25A44 may serve as a promising strategy to improve systemic 
BCAA clearance and glucose homeostasis.
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METHODS
Human subject
Thirty-three healthy young male volunteers were recruited in Sapporo, Japan to investigate 
the role of BAT in circulating BCAA clearance during cold exposure. All participants were 
carefully instructed regarding the study and provided written informed consent. The 
protocols were approved by the Institutional Research Ethics Review Board of Tenshi 
College (Sapporo, Japan) (UMIN000016361). Human BAT activity was assessed by 18F-
FDG-PET/CT scan (Aquiduo; Toshiba Medical Systems, Otawara, Japan) after the 
standardized non-shivering cold exposure, as reported previously 27. All the subjects have 
fasted for 12 hours prior to 18F-FDG-PET/CT scanning. Following cold exposure, the 
volunteers were given an intravenous injection of 18F-FDG (1.66–5.18 MBq/kg body 
weight) and subsequently stayed in the same cold room for another one hour. BAT activity 
was assessed by measuring the standardized uptake value (SUV) of 18F-FDG and 
Hounsfield Units from −300 to −10 in the supraclavicular region using the fusion software 
(Toshiba Medical Systems). Based on the median of BAT activity, subjects were divided into 
a high BAT activity group and a low BAT activity group. Arterialized blood samples were 
obtained from the same subject right before cold exposure and after 2-hour-cold exposure at 
19 °C between 9:00 am-11:30 am. Sera were used for metabolite analysis. Amino acid levels 
were corrected for total amino acid levels by means of linear regression, since individual 
variation in the most of amino acids (85.3%) can be explained by total amino acids. To 
minimize possible effects of seasonal variation on BAT, the study was performed from 
January to March where a monthly average of ambient temperature was 2.1 to −3.5°C in 
Sapporo, Japan.
Animals
All the animal experiments in this study were performed following the guidelines 
established by the UCSF Institutional Animal Care and Use Committee. All the mice were 
12–16 weeks old, had free access to food and water, 12-hour light cycles, and were caged at 
23 °C. For the generation of BAT-specific Bckdha KO mice (BckdhaUCP1 mice), Bckdha 
floxed mice were obtained from the EuMMCR (European Mouse Mutant cell Repository) 
(Bckdhatm1a(EUCOMM)Hmgu) and crossed with Ucp1-Cre mice 28. For the generation of BAT-
specific Pparg KO mice, Pparg floxed mice were obtained from the Jackson Laboratory 
(Stock #004584) and crossed with Ucp1-Cre mice. Both KO mice were in the C57BL/6 
background.
For metabolic studies, male Bckdha UCP1 KO and littermate control mice at 8 weeks old 
were fed on a high-fat diet (HFD, 60% fat, D12492, Research Diets) at ambient temperature. 
Fat mass and lean mass were measured in mice on a HFD for 10 weeks by Body 
Composition Analyzer EchoMRI (Echo Medical Systems). For glucose tolerance test, the 
mice fed with HFD for 10 weeks were fasted for 6 hours (from 8:00 to 14:00) and injected 
intraperitoneally with glucose (1.5 g kg−1 body weight). For ITT experiments, the mice fed 
with HFD for 11 weeks were fasted 3 hours (from 10:00 to 13:00) and injected 
intraperitoneally with insulin (0.875 U kg−1 body weight). Blood samples were collected at 
the indicated time points, and glucose levels were measured using blood glucose test strips 
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(Abbott). BCAA tolerance was performed in male Bckdha UCP1 KO and control mice on a 
HFD for 10 weeks. For BCAA clearance test, mice were exposed to cold temperature under 
the fasting condition, and blood samples were obtained at the indicated time points. For 
BCAA tolerance test, mice were received a single bolus of BCAA oral gavage (500 mg kg−1 
body weight; weight ratio, Val: Leu: Ile = 1: 1.5: 0.8) 29 and were exposed to cold at 12 °C 
under the fasting condition. Blood was corrected at the indicated time points and total 
plasma BCAA levels were measured by using a commercially available kit (ab83374, 
Abcam). Independently, plasma BCAA levels after 3 hours oral BCAA gavage were 
quantified by flow injection electrospray ionization tandem mass spectrometry and 
quantified by isotope dilution technique using a method described previously 30. Briefly, 
plasma samples were spiked with a cocktail of heavy-isotope internal standards (Cambridge 
Isotope Laboratories, MA, USA; CDN Isotopes, Canada), deproteinated with methanol, and 
esterified with butanol. Mass spectra for amino acid esters were obtained using neutral loss 
scanning methods. Ion ratios of analyte to respective internal standard computed from 
centroided spectra were converted to concentrations using calibrators constructed from 
authentic amino acids (Sigma, MO, USA; Larodan Sweden) and dialyzed Fetal Bovine 
Serum (Sigma, MO, USA).
dCas9-KRAB mice were generated according to the method reported using a site-specific 
integrase-mediated approach described in 22. In brief, transgenic mice dCas9-KRAB in the 
FVB background contain a CAG promoter within the Hipp11 (H11) locus expressing the 
nuclease-deficient Cas9 fused to the zinc-finger protein 10 (ZNF10) Krüppel-Associated 
Box (KRAB) repressor domain31, together with mCherry and the puromycin resistance 
cassette. dCas9-KRAB mice were backcrossed with wild-type C57BL/6J mice, and 
subsequently crossed with gRNA-Slc25a44 transgenic mice to generate Slc25a44 KD mice.
BAT-specific Slc25a44 KD mice (Slc25a44BAT KD) were generated by injecting AAV 
expressing gRNA-Slc25a44 (AAV8-CAG-EGFP-U6-gRNA-long tracr; custom order, Vector 
Biolabs) or control GFP (AAV8-CAG-EGFP) into interscapular BAT following the 
published protocol32. In short, AAV was injected into the interscapular BAT of dCas9-
KRAB adult mice at a viral titer of 6.0 ×1011 genomic copies (GC) per mice. Fifty μl of 
AAV at a dose of 1.2 × 1010 GC μl−1 was injected in each BAT depot (5 μl per injection, 10 
locations per depot). Efficacy of viral infection and knockdown was evaluated by 
immunohistochemistry for GFP, and quantification of SLC25A44 expression level.
Chemicals and antibodies
All the chemicals were obtained from Sigma-Aldrich unless otherwise specified. Following 
antibodies were used in this study: UCP1 antibody (ab-10983, Abcam), BCAT1 antibody 
(TA504360, OriGene), BCAT2 antibody (9432, Cell Signaling Tech), BCKDHA antibody 
(sc-271538, Santa Cruz), TOM20 antibody (11802–1-AP, Proteintech), COX-IV antibody 
(4850, Cell Signaling), OXPHOS cocktail (Abcam, ab110413), PDH-E1α antibody 
(sc-377092, Santa Cruz), PDH-E1α (pSer232) antibody (AP1063, Millipore), PDH-E1α 
(pSer293) antibody (ab177461, Abcam), PDH-E1α (pSer300) antibody (AP1064, 
Millipore), GAPDH antibody (sc-32233, Santa Cruz), and β-actin antibody (A3854, Sigma-
Aldrich). Polyclonal antibody for SLC25A44 was generated by using amino acids 
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(MEDKRNIQIIEWEHLDKKKC, MMQRKGEKMGRFQVC, and CKKLSLRPELVDSRH) 
as epitopes for immunization in rabbit (GeneScript).
Cell culture
Brown adipocyte and beige adipocyte lines from C57BL/6 mice were established in our 
previous study33. Similarly, immortalized human brown adipocyte and white adipocyte lines 
were established previously 15. Murine adipocyte differentiation was induced by treating 
confluent preadipocytes with DMEM containing 10% FBS, 0.5 mM isobutylmethylxanthine, 
125 nM indomethacin, 2 μg/ml dexamethasone, 850 nM insulin, 1 nM T3 and 0.5 μM 
rosiglitazone. Two days after induction, cells were switched to maintenance medium 
containing 10% FBS, 850 nM insulin, 1 nM T3 and 0.5 μM rosiglitazone. Mouse cells were 
fully differentiated 6–7 days after inducing differentiation. Immortalized human brown 
preadipocytes were cultured with animal component-free medium (Stem Cell Technologies; 
#05449). Brown adipocyte differentiation was induced by treating confluent preadipocytes 
with animal component free adipogenic differentiation medium (Stem Cell Technologies; 
#05412) supplemented with T3 (1 nM) and rosiglitazone (0.5 μM). Human cells were fully 
differentiated 4 weeks after induction. A mouse neuroblastoma line, Neuro2a (89121404, 
Sigma-Aldrich), was cultured in minimum essential medium Eagle (Sigma-Aldrich, M4655) 
containing 10% FBS, 1% non-essential amino acid solution (Sigma-Aldrich, M7145), and 
1% penicillin streptomycin solution on the collagen-coated plates. C2C12 cells were 
differentiated into myotubes by culturing confluent cells with DMEM supplemented with 
2% FBS and 850 nM insulin. HEK293S cells were infected with retrovirus expressing the C-
terminal Flag-tagged Slc25a44 or an empty vector and cultured in suspension with a 
FreeStyle 293 Expression Medium (Thermo Fisher; 12338018) supplemented with 2% FBS.
Stable isotope-labeled leucine metabolome analysis
To determine the metabolic fate and catabolic flux of Leu in brown adipocytes, we used 
[13C6, 15N1] Leu tracing followed by capillary electrophoresis time-of-flight mass 
spectrometry (CE-TOFMS, Agilent Technologies, Santa Clara, CA). Differentiated human 
brown adipocytes were incubated in the BCAA-free medium supplemented with 2 mM 
[13C6, 15N1] Leu (608068, Sigma-Aldrich) and were harvested at 1 hour after the treatment 
with norepinephrine, washed twice with 10 mL of 5% mannitol aqueous solution, and 
subsequently incubated with 1 mL of methanol containing 25 μM internal standards 
[methionine sulfone, 2-(N-morpholino)-ethanesulfonic acid (MES) and D-camphor-10-
sulfonic acid (CSA)] for 10 min. Four hundred μL of the extracts were mixed with 200 μL of 
Milli-Q water and 400 μL of chloroform and centrifuged at 10,000 g for 3 min at 4°C. 
Subsequently, 400 μL of the aqueous solution was centrifugally filtered through a 5-kDa cut-
off filter (Human Metabolome Technologies, Tsuruoka, Japan) to remove proteins. The 
filtrate was centrifugally concentrated and dissolved in 50 μL of Milli-Q water that 
contained reference compounds (200 μM each of 3-aminopyrrolidine and trimesate) 
immediately prior to metabolome analysis.
The concentrations of all the charged metabolites in samples were measured by CE-TOFMS, 
following the methods as previously reported 34. In brief, a fused silica capillary (50 μm i.d. 
× 100 cm) was used with 1 M formic acid as the electrolyte. Methanol/water (50% v/v) 
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containing 0.1 μM hexakis (2,2-difluoroethoxy) phosphazene was delivered as the sheath 
liquid at 10 μL/min. Electrospray ionization (ESI)-TOFMS was performed in positive ion 
mode, and the capillary voltage was set to 4 kV. Automatic recalibration of each acquired 
spectrum was achieved using the masses of the reference standards ([13C isotopic ion of a 
protonated methanol dimer (2 MeOH+H)]+, m/z 66.0632) and ([hexakis (2,2-
difluoroethoxy) phosphazene +H]+, m/z 622.0290). Quantification was performed by 
comparing peak areas to calibration curves generated using internal standardization 
techniques with methionine sulfone. The other conditions were identical to those described 
previously 34. To analyze anionic metabolites, a commercially available COSMO(+) 
(chemically coated with cationic polymer) capillary (50 μm i.d. x 105 cm) (Nacalai Tesque, 
Kyoto, Japan) was used with a 50 mM ammonium acetate solution (pH 8.5) as the 
electrolyte. Methanol/5 mM ammonium acetate (50% v/v) containing 0.1 μM hexakis (2,2-
difluoroethoxy) phosphazene was delivered as the sheath liquid at 10 μL/min. ESI-TOFMS 
was performed in negative ion mode, and the capillary voltage was set to 3.5 kV. For anion 
analysis, trimesate and CAS were used as the reference and the internal standards, 
respectively. The other conditions were identical to those described previously 35. Mole 
percent enrichment (MPE) of isotopes, an index of isotopic enrichment of metabolites, was 
calculated as the percent of all atoms within the metabolite pool that are labeled according to 
the established formula 18,19
DNA constructs for overexpression and knockdown studies
The lentiviral expression plasmid that encodes mouse Slc25a44 open reading frame was 
obtained from GeneCopoeia (EX-Mm15289-Lv207-GS). The Slc25a44 sequence was 
amplified from the lentiviral plasmid by PCR and cloned in-frame with a Flag sequence into 
the retroviral expression vector (Addgene, #75085). Lentiviral shRNA expression constructs 
targeting mouse Slc25a44 and Slc25a39 (shSlc25a44, CS-MSH073484-LVRU6GH-01; 
shSlc25a39, MSH034465-LVRU6GH; scrambled control, CSHCTR001-LVRU6GH), 
lentiviral shRNA expression constructs targeting human SLC25A44 (shSLC25A44, 
HSH057134-LVRH1H; scrambled control, CSHCTR001-LVRH1H), as well as lentiviral 
shRNA expression construct targeting mouse Ucp1 were obtained from GeneCopoeia 
(shUcp1, MSH028473-LVRH1MH). For virus production, HEK293T packaging cells were 
transfected with 10 μg of lentiviral or retroviral plasmids and the packaging constructs 
(VSVg, pMDL, and Rev) using a calcium phosphate method. After 48 h, the viral 
supernatant was harvested and filtered. Immortalized preadipocytes, Neuro2a or HEK293S 
cells were incubated overnight with the viral supernatant and supplemented with 10 μg/ml 
polybrene. Hygromycin at a dose of 50 or 200 μg/mL was used for selection of lentivirus-
infected human cells and murine cells, respectively. Blasticidin at a dose of 10 μg/mL was 
used for selection of retrovirus-infected cells.
Generation of Bckdha KO and Slc25a44 KO brown adipocytes
For generation of Bckdha KO brown adipocytes, preadipocytes isolated from BAT of 
Bckdhaflox/flox mice were immortalized by using the SV40 Large T antigen as described 
previously 15 and subsequently infected with retrovirus containing Cre (#34565, Addgene), 
followed by hygromycin selection at a dose of 200 μg/ml. For generation of Slc25a44-KO 
brown adipocytes, immortalized brown adipocyte cell line was infected with lentivirus 
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packaged by lentiCRISPRv2 (#98291, Addgene) expressing Cas9 and gRNA for Slc25a44 
(5’- GGTGCTCCCACTCGATGATC-3’). After selection with 200 μg/ml hygromycin 
followed by isolating a monoclonal cell, we confirmed homozygous mutations in the 
Slc25a44 genes by DNA sequencing.
RNA preparation, quantitative RT-PCR, and RNA-sequencing
Total RNA was extracted from tissue or cells using RNeasy mini-kit (Qiagen) and cDNA 
was synthesized using iScript cDNA Synthesis kit (BioRad) according to the provided 
protocols. qRT-PCR was performed using an ABI ViiA™7 PCR cycler. The primer 
sequences are listed in Supplementary Table 4. For RNA-sequencing, the libraries were 
constructed from total RNA and sequenced using a HiSeq 3000 instrument (Illumina) at the 
UCLA Technology Center for Genomics and Bioinformatics core by technical staffs who 
were blinded to the experimental group. Sequenced tags were pseudo-aligned to mouse 
reference transcriptome. Transcript-level estimated using Kallisto 0.44.0 were imported into 
R and expression levels per gene were estimated using the Bioconductor package tximport 
1.10.0.
BCAA oxidation assay
Differentiated adipocytes in a six-well plate were washed with PBS and incubated in 1 ml of 
Krebs-Ringer Modified Buffer (KRB)/HEPES buffer, containing 2% BSA, 15 mM glucose, 
200 nM adenosine, and either 0.16 μCi/ml [1-14C] Val together with 1 mM non-radioisotope 
(RI) Val or 0.16 μCi/ml [1-14C] Leu together with non-RI 1 mM Leu, at 37 °C for 2 hours. 
Subsequently, 350 μL 30% hydrogen peroxide was added in each well, and [14C] CO2 was 
trapped in the smears supplemented with 300 μL 1 M benzethonium hydroxide solution at 
room temperature for 20 min. Similarly, isolated tissue (20–30 mg) was placed in a 
plypropylene round-bottom tube and incubated in the 1 mL KRB/HEPES buffer containing 
0.16 μCi/ml [1-14C] Val at 37 °C for 1 hour. After adding 350 μL 30% hydrogen peroxide in 
the tube, [14C] CO2 was trapped in the center well supplemented with 300 μL 1 M 
benzethonium hydroxide solution for 20 min at room temperature. BCAA oxidation was 
quantified by counting radioactivity of trapped [14C] CO2 using scintillation counter.
Mitochondrial amino acid uptake assay
Differentiated adipocytes in 10 cm culture plates were washed in cold PBS and incubated 
with KPBS at 4 °C for 10 min. Confluent Neuro2a cells were incubated with KPBS without 
washing in PBS to minimize cell loss. After removing KPBS, mitochondria were isolated by 
using a mitochondria isolation kit (Thermo Fisher; 89874) according to the provided 
protocol. Isolated mitochondria were incubated with KRB/HEPES buffer, containing 2% 
BSA, 15 mM glucose, 200 nM adenosine, and either 0.32 μCi/ml [U-14C] Val, [U-14C] Leu, 
[U-14C] Ala, [U-14C] Phe, [U-14C] Thr, [U-14C] Glu, [U-14C] Asp, [U-14C] Lys, [U-14C] 
Arg (Moraveck), or [1-14C] α-ketoisovalerate (American Radiolabeled Chemicals) at 37 °C 
for 1 hour. After cooling down on ice, mitochondria were washed in chilled PBS three-times 
and homogenized in 100 μL RIPA buffer. Mitochondrial Val or Leu uptake was quantified by 
counting radioactivity using a scintillation counter and normalized by protein content.
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Liposome preparation
Egg phosphatidylcholine (1.280 mL, 25 mg/mL in CHCl3, Avanti Polar Lipids, 840051), 
E.coli polar lipid (1.344 mL, 25 mg/mL in CHCl3, Avanti Polar Lipids, 100600), and 
cardiolipin (0.640 mL, 10 mg/mL in CHCl3, Sigma-Aldrich, C0563) were mixed in round 
bottle flask. The solvent was removed by rotary evaporation under vacuum at room 
temperature to form a lipid film, which was further dried under strong vacuum for at least 2 
h to remove trace CHCl3. Four mL of 10 mM PIPES buffer pH7.4, which contains 25 mM 
non-radioisotope Leu and Glu as internal substrates, was gently added to the dried lipid film. 
The flask was kept overnight at 4 °C to allow the formation of large unilamellar vesicles 
(LUVs), followed by incubating at 70 °C for 30 min. The LUVs were extruded seven-times 
through an extruder (Avanti Polar Lipids, 610000), which was assembled with two drain 
disks separated with a 1.0 μm pore size polycarbonate membrane (GE Whatman, 889–
78159). The extruded liposome was concentrated to 40 mg/mL lipid concentration in 10 kDa 
centrifugal filters (Millipore, UFC505024).
Mitochondria-liposome assay
Mitochondria was isolated from differentiated Slc25a44 KO brown adipocytes stably 
expressing either Slc25a44 or an empty vector (90 plates/group). The mitochondrial 
membrane was obtained by mechanical disruption and sonication. Sonicated mitochondrial 
membrane (2 mg/mL) was fused with liposome (4 mg/mL) by incubating with 40 mM β-D-
Octyl glucoside (β-OG, Sigma-Aldrich, O8001) at 4 °C for 1 h in PIPES buffer containing 
non-radioactive Leu and Glu. After removal of β-OG by Bio-Beads SM-2 (Bio-Rad), 
mitochondria-liposome was isolated on Sepharose 4B columns (Sigma-Aldrich, 4B-200) to 
remove the external substrates. Mitochondria-liposomes were trapped on 10 kDa centrifugal 
filters (Millipore, UFC505024), eluted in 1200 μL PIPES buffer without non-radioactive Leu 
or Glu, and then used for uptake assays. Transports of [14C6] Leu or [14C5] Glu were 
initiated by incubating mitochondria-liposomes with either 20 μM [14C6] Leu or 20 μM 
[14C5] Glu at 37 °C and stopped by filtrating the reaction mixture with vacuum manifold 
(0.45 μm pore size) at the indicated time points. Following six-times washing with 600 μL 
ice-cold PIPES buffer, uptake was quantified by a scintillation counter.
Proteo-liposome assay
HEK293S cells stably expressing C-terminal Flag-tagged Slc25a44 were cultured in 9 L 
suspension medium, harvested, and disrupted with Dounce homogenizer in solubilization 
buffer [20 mM Tris-HCl, 100 mM NaCl, 10% glycerol, 1% DDM with 0.1 % CHS 
(Anatrace, D310-CH210), EDTA-free protease inhibitor (Roche)], followed by 
solubilization at 4 °C for 1 h. After ultracentrifugation at 200,000 x g for 20 min, the 
supernatant was incubated with Flag M2 affinity gel (Sigma-Aldrich, A2220) at 4 °C for 2 h. 
The immunoprecipitates were washed five times with washing buffer [20 mM Tris-HCl, 500 
mM NaCl, 10% glycerol, 0.1% DDM with 0.01 % CHS], followed by competitive elution 
using Flag peptide (Sigma-Aldrich, F4799) in SEC buffer [20mM Tris-HCl, 100 mM NaCl, 
10% glycerol, 0.1% DDM with 0.01 % CHS]. Purified c-Flag-SLC25A44 (56 μg) was fused 
with liposome (8 mg) by incubating at 4 °C for 1 h in 2 mL PIPES buffer containing 25 mM 
non-radioactive Leu and Glu in the presence of 40 mM β-OG. Following removal of β-OG 
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by Bio-Beads SM-2, proteo-liposome was isolated on Sepharose 4B columns to remove the 
external substrates. Subsequently, the proteo-liposomes were trapped on 10 kDa centrifugal 
filters, eluted in 1200 μL PIPES buffer without non-radioactive Leu or Glu, and then used 
for uptake assays. Transports of [14C6] Leu were initiated by incubating proteo-liposomes 
with 20 μM [14C6] Leu at 37 °C and stopped by filtrating the reaction mixture with vacuum 
manifold at the indicated time points. Following six-times washing with 600 μL ice-cold 
PIPES buffer, uptake was quantified by a scintillation counter.
Temperature recording
For core-body temperature recording experiments, rectal temperature of BckdhaUCP1 KO 
and Slc25a44 KD mice was monitored using a TH-5 thermometer (Physitemp) up to 14 
hours after cold exposure. For tissue temperature recording, mice under anesthesia were 
implanted with type T thermocouple probes in the interscapular BAT, inguinal WAT, liver, 
and skeletal muscle, according to the method that was described previously 33. Tissue 
temperature was recorded by TC-2000 Meter (Sable Systems International). When tissue 
temperature was stable, mice were intraperitoneally administered norepinephrine at a dose 
of 1 mg per kg body weight to induce non-shivering thermogenesis.
Electromyography (EMG)
Skeletal muscle shivering was assessed by using EMG recording, as reported in our previous 
study 33. In brief, mice were placed in a restrainer to limit free movement, and twenty-nine-
gauge needle electrodes were placed the back muscles of mice. The EMG signal was 
processed (low-pass filter, 3 kHz; high-pass filter,10 Hz; notch filter, 60 Hz) and amplified 
1,000× with Bio Amp (ADInstruments). EMG data were collected from the implanted 
electrodes at a sampling rate of 2 kHz using LabChart 8 Pro Software (ADInstruments). The 
raw signal was converted to RMS activity. RMS activity was analyzed for shivering bursts in 
10-s windows. For monitoring muscle shivering in humans, EMG at the pectoral muscle was 
recorded by using a surface EMG (Polymate II; TEAC). EMG was recorded for 10-min at 
27°C before cold exposure, and for another 10 min at 19 °C during the 2-hour-cold 
exposure.
18F-Fluciclovine-PET/CT scan
18F-Fluciclovine (100 μCi) was administered to male wild-type mice (C57Bl6/J) at 14–15 
weeks old via a tail vein injection under 2% isoflurane anesthesia after 6-h fasting. Mice 
were acclimated to either 30°C or cold temperature at 15°C for 2 weeks. 18F-Fluciclovine-
uptake (SUV) was measured every minute immediately after tail vein injection using micro-
PET/CT imaging system at the UCSF PET/CT Imaging Core Facility. Changes in SUV was 
quantified starting from the first 60 seconds after 18F-Fluciclovine injection by using 
software AMIDE 1.0.4 (Amide).
Oxygen consumption assays
Oxygen consumption rate (OCR) in cultured adipocytes was measured using the Seahorse 
XFe Extracellular Flux Analyzer (Agilent) in a 24-well plate. For measurement of NE-
induced respiration in the presence and absence of BCAA, differentiated adipocytes were 
Yoneshiro et al. Page 14
Nature. Author manuscript; available in PMC 2020 February 21.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
maintained in KRB/HEPES buffer containing 15 mM glucose, 200 nM adenosine, and 2% 
BSA. During OCR measurement, cells were treated with 2 mM BCAA (Val, Leu, or Ile), 2 
mM KIV, 10 mM succinate, or vehicle, and subsequently treated with NE (1 μM) at the 
indicated time point. For the mitochondrial stress test, differentiated brown adipocytes in a 
24-well plate were pretreated with 300 μM clofibrate, a BCAT2 activator, and subjected to 
respiratory assay. During OCR measurement, cells were treated with oligomycin (5 μM), 
carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP, 5 μM) and antimycin (5 
μM).
Mitochondrial electron transport (ETC) activity
ETC activity was assessed as reported previously 36. In brief, mitochondria were isolated 
from BAT of mice using a comitial kit (Ab110168, Abcam) and were resuspended in 300 μl 
of isolation buffer provided by the kit. After protein quantification by the BCA method, the 
mitochondrial suspension was diluted with isolation buffer at concentration 0.1 mg/ml, 
seeded into a 24-well plate (5 μg/50 μl/well), and adhered to the bottom of the plate by 
centrifugation 2,000 x g at 4°C for 20 min using microplate rotor adaptor. Immediately prior 
to the measurement, 450μl mitochondrial assay buffer (MAS) and substrates supplemented 
with pyruvate 10 mM, malate 5 mM, 50 mM KCl, 4 mM KH2PO4, 5 mM HEPES, 1 mM 
EGTA and 4% fatty-acid-free BSA was added to each well. During OCR measurement by 
the Seahorse XFe Extracellular Flux Analyzer, mitochondria were treated with 2 μM 
rotenone, 10 mM succinate, 5 μM antimycin A and 100 μM cN,N,N’,N’-Tetramethyl-p-
phenylenediamine (TMPD) with 10 mM ascorbate (Asc) at the indicated time points.
PDH activity and BCKDH assays
Tissue lysate was prepared by homogenizing BAT in ice-cold PBS buffer containing 
cOmplete Protease Inhibitor Cocktail (Roche) and 5 mM NaF. Two hundred micrograms of 
BAT lysates were applied to measure PDH enzymatic activities by a commercially available 
kit (Abcam, ab109902). The BCKDH activity measurement was performed as previously 
described 37.
Glucose oxidation assay
Differentiated adipocytes in a six-well plate were incubated in DMEM containing 2% FBS 
for 2 hours. After washing in PBS, cells were incubated in 1 ml of KRB/HEPES buffer, 
containing 2% BSA, 15 mM glucose, 200 nM adenosine, and 0.5 μCi/ml [1-14C] glucose, 
supplemented with or without 1 mM Val, at 37 °C for 2 hours. Subsequently, 350 μL 30% 
hydrogen peroxide was added in each well, and [14C] CO2 was trapped in the smears 
supplemented with 300 μL 1 M benzethonium hydroxide solution at room temperature for 
20 min. For the assay in tissues, mice were fasted for 6 hours and sacrificed. Isolated tissue 
(20–30 mg) was placed in a plypropylene round-bottom tube and incubated in the 1 mL 
KRB/HEPES buffer containing 1.0 μCi/ml [1-14C] glucose at 37 °C for 1 hour. After adding 
350 μL 30% hydrogen peroxide in the tube, [14C] CO2 was trapped in the center well 
supplemented with 300 μL 1 M benzethonium hydroxide solution for 20 min at room 
temperature. Glucose oxidation was quantified by counting radioactivity of trapped [14C] 
CO2 using scintillation counter.
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Fatty acid oxidation assay
Differentiated adipocytes were plated in a six-well plate and incubated in medium 
containing 2% FBS for 4 h. After washing in PBS, the cells were incubated in 1 ml of KRB/
HEPES buffer, containing 15 mM glucose, 0.1 mM oleic acid, and 0.5 μCi/ml [1-14C] oleic 
acid bound to 2% BSA and 100 μM carnitine, supplemented with or without 1 mM Val, for 2 
h at 37 °C. Then, 350 μL 30% hydrogen peroxide was added in each well to trap [14C] CO2 
in the smears supplemented with 300 μL 1 M benzethonium hydroxide solution. For the 
assay in tissues, mice were fasted for 4 hours and sacrificed. Isolated tissue (20–30 mg) was 
placed in a polypropylene round-bottom tube and incubated in the 1 ml KRB/HEPES buffer 
containing 1.0 μCi/ml [1-14C] oleic acid at 37°C for 1 hour. After adding 350 μl 30% 
hydrogen peroxide in the tube, [14C] CO2 was trapped in the center well supplemented with 
300 μl 1 M benzethonium hydroxide solution for 20 min at room temperature. Oleic acid 
oxidation was quantified by counting radioactivity of trapped [14C] CO2 using scintillation 
counter.
Immunoblotting
Protein lysates from isolated tissues or cultured cells were extracted using Qiagen 
TissueLyzer LT and RIPA lysis and extraction buffer (Thermo Fisher) and cOmplete 
protease inhibitors (Roche). Tissue lysates were applied to immunoblot analysis using the 
UCP1 antibody (1:2000), BCAT1 antibody (1:1000), BCAT2 antibody (1:1000), BCKDHA 
antibody (1:2000), TOM20 antibody (1:2000), COX-IV antibody (1:2000), OXPHOS 
cocktail (1:2000), PDH-E1α antibody (1:1000), PDH-E1α (pSer232) antibody (1:1000), 
PDH-E1α (pSer293) antibody (1:1000), PDH-E1α (pSer300) antibody (1:1000), and 
SLC25A44 antibody (1:1000). β-actin (1:10000) and GAPDH (1:2000) were used as a 
loading control for each sample.
Tissue histology and immunostaining
For hematoxylin and eosin (H&E) staining, tissues of mice were fixed in 4% 
paraformaldehyde overnight at 4 °C, followed by dehydration in 70% ethanol. After the 
dehydration procedure, tissues were embedded in paraffin, sectioned at a thickness of 5 μm, 
and stained with H&E following the standard protocol. For immunostaining, paraffin-
embedded tissues were deparaffinized twice in xylene and subsequently rehydrated. After 
incubating the slides for 20 min in boiling water, the tissues were blocked in PBS containing 
2% BSA for 60 min. After washing in PBS, the slides were incubated with the primary 
antibody (chicken anti-mouse GFP, 1:200) overnight at 4 °C, followed by incubation with 
the fluorescence-conjugated second antibody (goat anti-chicken IgG Alexa Fluor 488 green, 
1:500) for 1 hour at room temperature. After washing, the sections were stained with 4’,6-
diamidino-2-phenylindole (DAPI) and mounted with mounting medium (Cytoseal 60, 
Thermo-Scientific). Images of tissue samples were captured using the Inverted Microscope 
Leica DMi8.
Statistical analyses
All data were expressed as the means with SEMs and analyzed by using statistical software 
(SPSS 25.0; IBM Japan, Tokyo, Japan). Comparisons between the two groups were analyzed 
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using the paired t-test or the Student’s t-test, as appropriate. One-way or two-way ANOVA 
followed by Tukey’s test was used for multiple group comparisons. One-way or two-way 
repeated measures ANOVA was used for the comparisons of repeated measurements. 
Pearson’s and Spearman’s correlation coefficients were used to determine normally 
distributed variables and non-normally distributed variables, respectively. Two-tailed P value 
< 0.05 was considered as statistically significant.
Data availability
The RNA-seq data generated in this study is available at Array Express under the accession 
code E-MTAB-7987. 13C-Leu tracing data is available in Supplementary Table 3. 
Uncropped immunoblot images are available in Supplementary Figure 1. The other dataset 
that support the findings of this study are available in Supplementary Information and 
Source Data.
Extended Data
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Extended Data Fig. 1. Cold-induced changes in circulating metabolites in mice and humans.
a. Representative surface electromyogram (EMG) in adult humans at 27°C and following 
cold exposure at 19°C for 2 hours. Voluntary muscle contraction as a positive control of 
EMG recording.
b-c. Serum non-esterified fatty acids (NEFA) (b) and blood glucose (c) levels in high (n = 9) 
and low BAT subjects (n = 6) at 27°C and following cold exposure at 19°C.
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d. Correlation between BAT activity (SUV, log10) and cold-induced changes in serum amino 
acid levels of high (red dots) and low BAT subjects (blue dots). n = 33/group (all amino 
acids) except n = 29 (Asp).
e. Correlation between fat-free mass (kg) and changes in serum total BCAAs in (d). n = 33.
f. Changes in plasma BCAA levels at thermoneutral (TN, 30°C) or cold exposure (15°C) in 
diet-induced obese mice. n = 8 (TN), n = 7 (cold).
b-f, biologically independent samples. Mean ± s.e.m.; two-sided P-values by paired t-test 
(b,c) or two-way repeated measures ANOVA followed by post-hoc paired/unpaired t-tests 
with Bonferroni’s correction (f). Pearson’s (r) or Spearman’s rank correlation coefficient (rs) 
was calculated, as appropriate (d,e).
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Extended Data Fig. 2. The BCAA catabolic pathway in human and mouse adipose tissues.
a. 18F-Fluciclovine-uptake into indicated organs determined by dynamic PET scanning. n = 
5/group.
b. Valine oxidation (per mg tissue) in indicated tissues of mice acclimated to 23°C or 12°C 
for one week. n = 5/group.
c. Total valine oxidation in (b). Total Val oxidation was calculated by multiplying Val 
oxidation per mg tissue (cpm/mg tissue) and tissue mass of the depot (mg).
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d. Valine oxidation normalized by total protein (μg) in human brown adipocytes and white 
adipocytes following 2-hour-treatment with NE or vehicle. n = 5 (Veh), n =6 (NE).
e. Expression profile of BCAA catabolic enzymes enriched in brown/beige fat relative to 
white fat of humans (left) and mouse (middle, right). Data were obtained from previous 
RNA-seq dataset in humans15 and microarray dataset in mice17. The profiles were mapped 
onto the KEGG BCAA catabolic pathway. The number of brown/beige-enriched enzymes 
among total BCAA catabolic enzymes is shown. n = 3/group.
f. Proteomic profile of indicated enzymes in the BCAA oxidation pathway and 
mitochondrial carriers (SLC25A families) in interscapular BAT of mice at thermoneutrality 
(29°C) or 5°C for 3 weeks16. n = 4/group.
g. Transcriptional profile of indicated genes in the glucose oxidation pathway (left) and the 
BCAA oxidation pathway (right) in the supraclavicular BAT and abdominal WAT from the 
identical subject under a thermoneutral condition (TN, at 27°C) and after cold exposure at 
19°C5. Color scale represents Z-scored FPKM (fragments per kilobase of exon per million 
fragments mapped).
h. mRNA expression level (FPKM) of Bcat1 and Bcat2 in differentiated brown adipocytes, 
beige adipocytes, and white adipocytes. The transcriptome data are from previous RNA-seq 
dataset15.
i. Immunoblotting of BCAT1 and BCAT2 in indicated tissues of mice kept at ambient 
temperature. GAPDH as a loading control. Representative result from two independent 
experiments. Gel source data are in Supplementary Figure 1.
a-h, biologically independent samples. Mean ± s.e.m.; two-sided P-values by unpaired 
Student’s t-test (b,c,f), two-way repeated measures ANOVA (a), or two-way factorial 
ANOVA followed by Tukey’s post-hoc test (d).
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Extended Data Fig. 3. Characterization of BAT-specific Bckdha KO mice.
a. mRNA expression of Bckdha in BAT of BckdhaUCP1 KO and littermate control mice. n = 
5/group for all groups except n = 3 for control-gastrocnemius.
b. Valine oxidation normalized by tissue weight (mg) in indicated tissues of mice in (a). n = 
5/group.
c. Enzymatic activity of BCKDH complex (KIV oxidation) in BAT of control and 
BckdhaUCP1 KO mice acclimated to 23°C (n = 3/group) or 12°C (n = 5/group) for one week.
d. Tissue weights of mice in (a) on a normal chow at ambient temperature. n = 4/group.
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e. mRNA expression of indicated genes in BAT of mice in (a). n = 5/group.
f. EMG of muscle shivering in control (n = 7) and BckdhaUCP1 KO mice (n = 9) at 30 ºC or 
8 ºC. The right graph shows quantitative root mean square (RMS) of EMG.
g. Liver temperature of control and BckdhaUCP1 KO mice following NE treatment. n = 4/
group.
h. Plasma amino acid levels after three hours BCAA oral gavage. n = 5/group.
i. Plasma BCAA concentration of control (n = 7) and BckdhaUCP1 KO mice (n = 9) 
following cold exposure at 8ºC.
a-i, biologically independent samples. Mean ± s.e.m.; two-sided P-values by unpaired 
Student’s t-test (a,b,d,e,h), two-way factorial ANOVA followed by Tukey’s post-hoc test 
(c), or two-way repeated measures ANOVA (f,g,i) followed by post-hoc paired/unpaired t-
tests with Bonferroni’s correction (f,i).
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Extended Data Fig. 4. The effect of norepinephrine on BCAA metabolism in brown adipocytes.
a. Scheme of the metabolic tracer experiment in human brown adipocytes. Cells were treated 
with vehicle or NE for one hour in the presence of [13C6, 15N1] Leu. CE-TOFMS, capillary 
electrophoresis time-of-flight mass spectrometry.
b. Isotopologue distributions of TCA intermediates from [13C6, 15N1] Leu in (a). n = 6/
group.
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c. Protein expression of indicated BCAA catabolic enzymes at indicated time points of cold 
acclimation. The expression profile is analyzed in the proteomics dataset16. n = 4 (TN, cold 
3 weeks), n = 3 (cold 8 hours, 1 day, 3 days, 1 week).
d. The BCAA catabolic pathway that indicates Val and Leu catabolic enzymes. Enzymes 
whose protein expression was transiently upregulated by acute cold exposure were 
highlighted in red based on the results in (c). Enzymes whose protein expression was 
gradually upregulated following chronic cold adaptation were highlighted in blue.
e. OCR normalized by total protein (μg) in human brown adipocytes. Differentiated 
adipocytes in the BCAA-free medium were supplemented with Val or vehicle, and 
subsequently stimulated with NE. n = 10/group.
f. Schematics of the mitochondrial Val catabolic pathway. Vanadate and malonate inhibit 
succinyl coenzyme A synthetase (SCS) and succinate dehydrogenase (SDH), respectively.
g. NE-induced OCR in the presence and absence of Val in mouse brown adipocytes. 
Following pretreatment with vanadate (50 μM) or malonate (5 mM), differentiated cells in 
the BCAA-free medium were supplemented with Val or vehicle, and subsequently treated 
with NE. n = 9 (vehicle), n = 8 (Val), n = 4 (vehicle+vanadate, Val+vanadate), n = 5 (vehicle
+malonate, Val+malonate).
h. NE-induced OCR in the presence and absence of BCAAs in mouse brown and white 
adipocytes. Differentiated cells were supplemented with indicated amino acids, and 
subsequently treated with 1 μM NE. Brown adipocytes: n = 10 (Val−, Val+, Ile+), 9 (Leu−), 
5 (Leu+), and 11 (Ile−). White adipocytes: n = 9 (Val−), and 10 (Val+).
i. NE-induced OCR in the presence and absence of Val in wild-type, Ucp1 KO, and Bckdha 
KO brown adipocytes. Bckdha KO brown adipocytes were treated with 2 mM KIV, 10 mM 
succinate, or vehicle prior to NE stimulation. Wild type: n = 10 (Val−) and 9 (Val+). Ucp1 
KO: n = 10 (Val−, Val+). Bckdha KO: n = 7 (Val+), 9 (Val+; KIV+), and 10 (Val+; succinate
+).
j. OCR normalized by total protein (μM) in wild-type (left) and Bcdkha KO brown 
adipocytes (right). Differentiated adipocytes were pretreated with BCAT2 activator, 
clofibrate (300 μM), or vehicle. Following measurement of basal OCR, cells were treated 
with oligomycin (5 μM), FCCP (5 μM), and AA (5 μM). Wild type: n = 5/group. Bckdha 
KO: n = 5/group.
b,c,e,g-j, biologically independent samples. Mean ± s.e.m.; two-sided P-values by unpaired 
Student’s t-test (b,g,h), one-way factorial ANOVA followed by Tukey’s post-hoc test (i) or 
two-way repeated measures ANOVA (e,i).
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Extended Data Fig. 5. Metabolic characterization of BckdhaUCP1 knockout mice.
a. Cumulative food intake of BckdhaUCP1 KO (n = 15) and littermate controls (n = 13) on 
HFD.
b. Fat mass and lean mass of mice in (a) at 10 weeks of HFD.
c. Tissue weights of in (a).
d. Triglyceride (TG) content in the liver of mice in (a). n = 8/group.
e. Oleic acid oxidation normalized by tissue mass (mg) in the interscapular BAT of mice 
acclimated to thermoneutral 30°C or cold exposure at 12°C. n = 4/group.
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f. PDH activity in the inguinal WAT, gastrocnemius muscle, and liver of BckdhaUCP1 KO 
mice and littermate controls that were exposed to cold at 12 °C for one week. Ing-WAT: n = 
5 (control) and 6 (BckdhaUCP1 KO). Gastrocnemius, liver: n = 4/group.
g. Immunoblotting for PDH-E1α(pSer232), PDH-E1α(pSer293), PDH-E1α(pSer300), and 
total PDH-E1α in the BAT of the control and BckdhaUCP1 KO mice. GAPDH as a loading 
control. n = 4/group. Uncropped immunoblot images of are available in Supplementary 
Figure 1.
h. Quantification of phosphorylated PDH-E1α normalized by total PDH-E1α protein level 
in (g).
a-h, biologically independent samples. Mean ± s.e.m.; two-sided P-values by unpaired 
Student’s t-test (b-d,f,h), two-way repeated measures ANOVA (a) or two-way factorial 
ANOVA followed by Tukey’s post-hoc test (e).
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Extended Data Fig. 6. Characterization of SLC25A44 in thermogenic adipocytes.
a. Expression profile of Slc25a family members in the inguinal WAT of mice acclimated to 
23°C or 12°C for one week. n = 3/group.
b. mRNA expression of UCP1, SLC25A44, and SLC25A39 normalized to TBP levels in the 
supraclavicular BAT from the same individuals (6 pairs) at thermoneutrality (TN, 27°C) and 
cold temperature (19°C).
c. Mitochondrial localization of SLC25A44 protein in differentiated mouse beige 
adipocytes. TOM20 as a mitochondrial marker.
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d. Immunoblotting for SLC25A44 in BAT and liver of control and Slc25a44 KD mice. 
GAPDH as a loading control. Red arrows indicate specific bands whose intensities were 
decreased in Slc25a44 KD mice.
e. mRNA expression of Slc25a44 and indicated genes normalized by 36B4 levels during 
mouse brown adipogenesis. n = 4/group.
f. Protein expression of SLC25A44 in mouse beige preadipocytes and differentiated 
adipocytes. β-actin as a loading control.
g. Protein expression of UCP1 and SLC25A44 in immortalized human brown preadipocytes 
and differentiated adipocytes. β-actin as a loading control.
a,b,e, biologically independent samples. Means ± s.e.m.; one-sided P-values by paired t-test 
(b) and two-sided P-values by unpaired Student’s t-test (a). c,d,f,g, representative results 
from two independent experiments. Uncropped images are available in Supplementary 
Figure 1.
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Extended Data Fig. 7. Biochemical characterization of SLC25A44.
a. Genomic Slc25a44 sequence and amino acid sequence of Slc25a44 KO brown cell line. 
Homozygous mutation in the Slc25a44 gene by CRISPR-Cas9 results in a premature stop 
codon in KO cells.
b. Scheme of mitochondrial BCAA uptake assay. Isolated mitochondria from differentiated 
brown adipocytes were incubated with [U-14C5] Val. Mitochondrial uptake was quantified 
by a scintillation counter.
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c. Validation of mitochondrial Val uptake assay in differentiated brown adipocytes. Note that 
addition of excess non-labeled Val (20 mM) abolished [U-14C5] Val uptake into the 
mitochondria.
d. mRNA expression of Slc25a44 and Slc25a39 in differentiated mouse brown adipocytes 
expressing a scrambled control shRNA (Scr) and shRNAs targeting Slc25a44 (shRNA #1, 
#2), Slc25a39, or both Slc25a44 shRNA #1 and Slc25a39 shRNA (double knockdown). n = 
4/group for all group except n = 6 for Scr control.
e. Mitochondria uptake of [U-14C5] Val (left) and [U-14C6] Leu (right) in brown adipocytes 
in (d). n = 3/group.
f. mRNA and protein expression of Slc25a44 in mitochondria of Neuro2a cells expressing an 
empty vector or Slc25a44. COX-IV as a loading control. n = 3/group.
g. Immunoblotting for SLC25A44 in the isolated mitochondria from differentiated Slc25a44 
KO brown adipocytes expressing an empty vector or Slc25a44. TOM20 as a loading control.
h. Immunoblotting of SLC25A44 in the mitochondria-fused liposome. Mitochondrial 
membrane isolated from Slc25a44 KO brown adipocytes expressing an empty vector or 
Slc25a44 was fused with liposome. TOM20 as a loading control.
i. [U-14C6] Leu uptake rate in the liposome in (h). n = 3/group.
j. [U-14C5] Glutamate (Glu) uptake rate in the liposome in (h). n = 3/group.
k. Coomassie-blue staining of purified SLC25A44 protein from HEK293S cells 
overexpressing Slc25a44.
l. Immunoblotting of SLC25A44 in liposomes reconstituted with purified SLC25A44 
(proteo-liposome) and liposomes reconstituted without SLC25A44 (empty liposome).
m. Left: [U-14C6] Leu transport into proteo-liposome in (l). Right: Leucine uptake rate. n = 
3/group.
d-f, biologically independent samples. i,j,m, technically independent samples. f-m, 
representative result from two independent experiments. Means ± s.e.m.; two-sided P-values 
by unpaired Student’s t-test (f,i,j,m) or one-way ANOVA followed by Tukey’s post-hoc test 
(d,e). f-h,k-l, uncropped images are available in Supplementary Figure 1.
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Extended Data Fig. 8. Generation of Slc25a44BAT knockdown mice.
a. DNA constructs used in the generation of dCas9-KRAB mice. The dCas9-KRAB 
construct was inserted into the Hipp11 (H11) gene locus by the site-specific PhiC31 
integrase.
b. Experimental procedure of gRNA screening. MEFs from dCas9-KRAB mice were used to 
identify gRNA that effectively deplete Slc25a44. The right graph: Slc25a44 knockdown 
efficiency for six independent gRNAs in the dCas9-KRAB-derived MEFs (n = 2/group). 
gRNA-Slc25a44 #1 (indicated by a red arrow) was used for generation of gRNA Tg mouse.
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c. Schematics of BAT-specific Slc25a44 KD mice (Slc25a44BAT KD) by using the dCas9-
KRAB system. AAV8-CAG-EGFP-U6-gRNA-tracr targeting Slc25a44 was injected into the 
interscapular BAT of mice expressing dCas9-KRAB on the H11 locus (dCas9-KRAB 
mouse). AAV8-CAG-EGFP without gRNA was used as a control.
d. mRNA expression of Gfp normalized by 36B4 in the indicated tissues of dCas9-KRAB 
mice in (c). n = 4/group.
e. H&E staining of inguinal WAT and liver of control and Slc25a44BAT KD mice.
b,d, biologically independent samples. Means ± s.e.m.; two-sided P-values by unpaired 
Student’s t-test (d).
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Extended Data Fig. 9. Characterization of Slc25a44 knockdown mice.
a. Generation of Slc25a44 KD mice by the dCas9-KRAB system. The dCas9-KRAB mouse 
was crossed with transgenic mouse expressing gRNA targeting Slc25a44 to generate 
SLC25A44 deficient mice.
b. Slc25a44 mRNA expression normalized by 36B4 levels and protein expression in the 
BAT of mice in (a). β-actin as a loading control. n = 5 (control), and 4 (Slc25a44 KD).
c. Expression profile of Slc25a family members in BAT in (a) by RNA-seq analysis. The 
color scale shows Z-scored fold change in FPKM (Slc25a44 KD vs control). n = 3/group.
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d. mRNA expression of Slc25a families normalized by 36B4 levels in Slc25a44 KO and 
control brown adipocytes. n = 6/group.
e. H&E staining of BAT, inguinal WAT, liver, and gastrocnemius muscle from mice in (a).
f. Triglyceride (TG) content in the interscapular BAT of Slc25a44 KD and control mice. n = 
4/group.
g. Expression profile of fatty acid synthesis- and oxidation-related genes in BAT of mice in 
(a) by RNA-seq analysis. The color scale shows Z-scored fold change in FPKM (Slc25a44 
KD vs control). n = 3/group.
h. Oleic acid oxidation normalized by tissue mass (mg) in BAT of Slc25a44 KD and control 
mice acclimated to thermoneutral 30°C or cold temperature (12°C) for one week. n = 4/
group.
i. EMG measurement of muscle shivering in control mice and Slc25a44 KD mice at 30 ºC or 
8 ºC. The lower graph shows the quantitative root mean square (RMS) of the EMG. n = 6/
group.
j. Tissue temperature in indicated tissues of control and Slc25a44 KD mice following NE 
treatment (indicated by red arrows). n = 4/group.
b-d,f-j, biologically independent samples. Means ± s.e.m.; two-sided P-values by unpaired 
Student’s t-test (b-d,f-g), two-way factorial ANOVA followed by Tukey’s post-hoc test (h), 
or two-way repeated measures ANOVA (i,j) followed by post hoc paired/unpaired t-test with 
Bonferroni’s correction (i). b,e, representative results from two independent experiments. 
Uncropped immunoblot images are available in Supplementary Figure 1.
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Extended Data Fig. 10. The cell-autonomous role of SLC25A44 in brown adipocytes.
a. Immunoblotting of SLC25A44 in human brown adipocytes expressing a scrambled 
control shRNA (Scr) and shRNAs targeting SLC25A44 (#1, #2). β-actin as a loading 
control.
b. mRNA expression of SLC25A44 normalized by TBP levels in (a). n = 3/group.
c. NE-induced OCR normalized by total protein (μg) in the presence and absence of Val 
supplementation in (a). Differentiated human brown adipocytes in the BCAA-free medium 
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were supplemented with Val or vehicle, and subsequently treated with NE. n = 9/group (Scr 
control, sh-Slc25a44 #1), n = 10/group (sh-Slc25a44 #2).
d. Means NE-induced OCR in (c).
e. Illustration of Val metabolism in the mitochondria.
f. Immunoblotting of mitochondrial proteins (as indicated) in the interscapular BAT of 
control and Slc25a44 KD mice. GAPDH as a loading control.
g. ETC activity of BAT mitochondria. Isolated mitochondria from BAT of control mice and 
Slc25a44 KD mice were treated with rotenone (2 μM), succinate (10 mM), AA (5 μM), and 
TMPD (100 μM) with ascorbate (Asc, 10mM). n = 5/group.
h. mRNA expression of Slc25a44 normalized by 36B4 in mouse beige adipocytes 
expressing an empty vector (n = 3) or Slc25a44 (n = 4).
i. Mitochondrial Val uptake in beige adipocytes in (h). n = 3/group.
j. NE-induced OCR in (h). Differentiated adipocytes in the BCAA-free medium were 
supplemented with Val or vehicle, and subsequently stimulated with NE. Vector: n = 20 
(vehicle) and 16 (Val). Slc25a44: n = 13 (vehicle) and 16 (Val).
k. Immunoblotting of SLC25A44 in C2C12 myotubes expressing an empty vector or 
Slc25a44. β-actin as a loading control.
l. Valine oxidation normalized by total protein (μg) in C2C12 myotubes in (k). n = 6/group.
m. OCR normalized by total protein (μg) in C2C12 myotubes in (k). n = 9/group.
b-d,g-j,l-m, biologically independent samples. Means ± s.e.m; two-sided P-values by 
unpaired Student’s t-test (h,i,l,m), one-way (b) or two-way (d,j) factorial ANOVA followed 
by Tukey’s post-hoc test, or two-way repeated measures ANOVA (c,g). a,f,k, representative 
results from two independent experiments. Uncropped immunoblot images are available in 
Supplementary Figure 1.
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Figure 1. Cold-induced BAT thermogenesis promotes systemic BCAA clearance in mice and 
humans.
a. 18F-FDG-PET/CT images of subjects following cold exposure. Right graph: quantitative 
standardized uptake values (SUV) of 18F-FDG in the BAT deposits. n = 17 (High BAT), n = 
16 (Low BAT).
b. Circulating Val concentration in (a) at 27°C (TN) and at 19°C (cold).
c. Correlation between BAT activity and cold-induced changes in serum Val concentration in 
(a).
d. Correlation coefficient between cold-induced amino acid changes and BAT activity (y-
axis) against the degree of BAT-dependent amino acid changes (x-axis) in (a).
e. Cold-induced changes in plasma amino acids in diet-induced obese mice at 30°C (TN, n = 
5) or 15°C (cold, n = 6).
f. 18F-Fluciclovine-PET/CT images of mice acclimated to 30°C (TN) or 15°C (cold) for 2 
weeks. Arrows indicate interscapular BAT.
g. SUV of 18F-fluciclovine in BAT. n = 5/group.
h. Morphology and H&E staining of interscapular BAT of PpargUCP1 KO and controls. 
Scale bar: 50 μm. Representative result from two independent experiments
i. Plasma BCAA levels in (h) during cold temperature at 12°C. n = 7/group.
a-i, biologically independent samples. Mean ± s.e.m.; two-sided P-values by paired t-test 
(b), unpaired Student’s t-test (e), or two-way repeated measures ANOVA (g) followed by 
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post-hoc paired/unpaired t-tests with Bonferroni’s correction (i). Pearson’s or Spearman’s 
rank correlation coefficient was calculated, as appropriate (c,d).
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Figure 2. BCAA oxidation in BAT is required for BCAA clearance and energy homeostasis.
a. Immunoblotting of BCKDHA in BAT of BckdhaUCP1 KO and controls. GAPDH as a 
loading control. Representative result from two independent experiments. Gel source data 
are in Supplementary Figure 1.
b. Rectal core-body temperature following cold exposure at 8°C. n = 8 (control), n = 9 
(BckdhaUCP1 KO).
c. Tissue temperature in BAT and muscle following NE treatment. n = 4/group.
d. Plasma BCAA levels at indicated time points after a BCAA oral gavage at 12°C. n = 8/
group.
e. MPE of indicated metabolites derived from [U-13C6] Leu in human brown adipocytes. 
Cells were treated with vehicle or NE for one hour. n = 6/group.
f. Body weight of BckdhaUCP1 KO (n = 15) and controls (n = 13) on HFD at ambient 
temperature.
g. Glucose tolerance test in (f).
h. insulin tolerance test in (f).
i. Glucose oxidation in BAT normalized by tissue mass. n = 3/group.
j. PDH activity in BAT of mice at 12°C for one week. n = 5 (control), n = 6 (BckdhaUCP1 
KO).
b-j, biologically independent samples. Mean ± s.e.m.; two-sided P-values by unpaired 
Student’s t-test (e,i,j) or two-way repeated measures ANOVA (b-d,f) followed by post-hoc 
unpaired t-test (g,h).
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Figure 3. Identification of SLC25A44 as a mitochondrial BCAA transporter.
a. Expression profile of SLC25A family members in human supraclavicular BAT and 
abdominal subcutaneous WAT from the same individual at 27°C and 19°C5.
b. Correlation of SLC25A44 mRNA expression with UCP1 or BCKDHA in human BAT. 
Expressions at TN (red) and cold (blue) from 6 biological independent subjects. Pearson’s 
correlation coefficient was calculated.
c. Protein expression of SLC25A44 in indicated tissues of mice. GAPDH as a loading 
control. Representative result from two independent experiments. Gel source data are in 
Supplementary Figure 1.
d-e. Mitochondrial uptakes of indicated molecules in control and Slc25a44 KO brown 
adipocytes (d) or in Neuro2a cells expressing Slc25a44 or an empty vector (e). n = 3/group, 
biologically independent samples.
f. [U-14C6] Leu transport into mitochondrial-liposomes from Slc25a44 KO brown adipocytes 
expressing an empty vector (KO+vector) or Slc25a44 (KO+Slc25a44). n = 3/group, 
technically independent samples. Representative result from two independent experiments.
Mean ± s.e.m.; two-sided P-values by unpaired Student’s t-test (d, e) or two-way ANOVA 
(f).
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Figure 4. SLC25A44 is required for BAT thermogenesis and BCAA catabolism.
a. Slc25a44 mRNA expression in indicated tissues of Slc25a44BAT KD and control mice. n 
= 4/group.
b. Immunoblotting of SLC25A44 in BAT of mice in (a). β-actin as a loading control. 
Representative result from two independent experiments. Gel source data are in 
Supplementary Figure 1.
c. Morphology, H&E staining, and immunofluorescent GFP staining of BAT in (a). DAPI 
was used for counter staining. Scale bar: 100 μm. Representative result from two 
independent mice.
d. Tissue temperature of BAT and muscle in (a) following NE treatment (arrows). n = 5 
(control), n = 7 (Slc25a44BAT KD).
e. Rectal core-body temperature of Slc25a44 KD (n = 6) and controls (n = 7) following cold 
exposure at 8°C.
f. Valine oxidation in indicated tissues normalized by tissue mass. n = 4/group.
g. Plasma BCAA levels in (e) following 8-hour cold temperature at 8°C. n = 6/group.
h. NE-induced OCR normalized by total protein in control and Slc25a44 KO brown 
adipocytes. n = 9/group (Ctrl+Val, KO+Val+KIV), n = 10/group (KO+Val, KO+Val
+succinate).
i. Valine oxidation in inguinal WAT-derived white adipocytes expressing an empty vector or 
Slc25a44 after NE treatment. n = 5 (vehicle), n = 6 (NE).
j. A proposed model of BCAA catabolism in thermogenic adipose cells. Cold stimuli 
activate BCAA uptake and oxidation in the mitochondria of thermogenic adipocytes. 
Mitochondrial BCAA oxidation promotes BAT thermogenesis. This process requires 
SCL25A44, the mitochondrial BCAA transporter. SLC7A5, L-amino acid transporter 1. 
Norepinephrine, NE.
a,d-i, biologically independent samples. Mean ± s.e.m.; two-sided P-values by unpaired 
Student’s t-test (a,f), one-way factorial (h) or two-way repeated measures ANOVA (d,e,g) 
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followed by post-hoc paired/unpaired t-test with Bonferroni’s correction (g) or Tukey’s test 
(h,i).
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